The NRG Oncology clinical trial BR001 tested the hypothesis that stereotactic body radiotherapy (SBRT) could be used safely in oligometastatic patients with multiple metastases. Results from the trial indicate that utilizing SBRT is safe as treatment for patients with 2 metastases in close proximity, or 3-4 metastases regardless of proximity, in seven anatomic locations.

At the 2018 Radiological Society of North America (RSNA) annual meeting, Nov. 25-30 in Chicago, Konica Minolta Healthcare Americas Inc. will showcase new advancements of the AeroRemote platform. AeroRemote Insights is a comprehensive performance dashboard for AeroDR Wireless Flat Panel Detector Systems that automatically collects and aggregates AeroDR system health and usage data into simple yet powerful analytical views.

Radiologists are under increasing pressure to be more and more efficient.  And with that pressure, their interest in artificial intelligence (AI) is growing. The hope is that AI might help them get things done.

An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized prostate cancer with hypofractionated intensity modulated radiation therapy (HIMRT) yields equivalent disease outcomes compared with conventional intensity modulated radiation (CIMRT). It is the largest randomized single-institution study with the longest follow-up period on this topic to date.

Vygon, an international group specialized in single-use medical devices, and French company Sonoscanner announced the design and development of the VysionXS, a new ultrasound scanner dedicated to vascular access catheterization guidance.

Carestream announced it will be displaying several imaging and healthcare information technology (IT) offerings at the 2018 Radiological Society of North America (RSNA) annual meeting, Nov. 25-30 in Chicago.

Medical imaging software company Mirada Medical showcased its DLCExpert at the recent American Society for Radiation Oncology (ASTRO) 2018 annual meeting, oct. 21-24 in San Antonio, Texas. The product, which has received U.S. Food and Drug Administration (FDA) 510(k) clearance, is the world’s first artificial intelligence (AI)-powered autocontouring solution. The software is already in use in multiple academic medical centers worldwide.

There’s a new modality in radiology, one that takes advantage of digital radiography (DR) and reflects the tenets of value-based medicine — low cost, high information and low radiation dose to patients.

The FDA has not cleared this modality, but it has shown promise managing patients suffering from lung dysfunction as well as injury to musculoskeletal tissues.

Volpara Solutions announced that the data stored in the Volpara Enterprise cloud now exceeds 1 million mammographic studies. Analysis of this anonymized  big data, reflecting the state of mammography in 2018, helps mammography providers achieve improved mammographic sensitivity and detect breast cancers at an earlier stage. It also helps breast imaging centers better understand how their image quality compares to that of other facilities and how to improve their mammograms going forward.

A new analysis of nearly 600 men receiving brachytherapy for prostate cancer shows overall procedure-related complications within four months of treatment is less than 20 percent. All patients were treated at Fox Chase Cancer Center in Philadelphia.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now